The Global Strategy model portfolio has added an approximate 5% position in BIIB, Biogen Idec and also an approximate 5% position in HLF, Herbalife.
The position in SHY was reduced from approximately 35% to 32%, and the cash position was reduced by approximately 7%.
DISCLAIMER: Nothing in this article should be construed as a personal recommendation or advice. Nor should anything in this article be construed as an offer, or a solicitation of an offer, to sell or buy any investment security.
The BIA Global Strategy Model Portfolio engages in short term aggressive, speculative strategies with an appropriate portion of an investor’s overall investable assets. Investors should conduct their own due diligence and seek the advice of a financial and/or investment professional before making any investment decisions